Send Email

Recipient(s) will receive an email with a link to 'Plasminogen' and will have access to the topic for 7 days.

Subject: Plasminogen

(Optional message may have a maximum of 1000 characters.)



  • Plasminogen is the inactive, circulating precursor of plasmin, the final product of the fibrinolytic system. Therapy with plasminogen activators results in the generation of plasmin and intended thrombolysis.

  • Normal range: 70–113%.


Decreased In

  • Congenital: rare reported cases; may result in a predisposition to thrombosis

  • Acquired: severe DIC, pathologic fibrinolysis, or as the result of thrombolytic therapy, and in liver disease